This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Metra, M. Articles by Dei Cas, L. Search for Related Content PubMed PubMed Citation Articles by Metra, M. Articles by Dei Cas, L.

CLINICAL STUDIES

Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure

Marco Metra, MD^*, Pompilio Faggiano, MD, Antonio D’Aloia, MD^*, Savina Nodari, MD^*, Anna Gualeni, MD^*, Domenica Raccagni, MD^* and Livio Dei Cas, MD^*

^* Cattedra di Cardiologia, Universitá di Brescia, Brescia, Italy
Divisione di Cardiologia, Ospedale Fatebenefratelli, Brescia, Italy

Manuscript received October 9, 1997; revised manuscript received October 23, 1998, accepted December 11, 1998.

Reprint requests and correspondence: Dr. Marco Metra, Cattedra di Cardiologia, Università di Brescia, c/o Spedali Civili, P.zza Spedali Civili 25100 Brescia, Italy.
deicas{at}master.cci.unibs.it

OBJECTIVES

We studied whether direct assessment of the hemodynamic response to exercise could improve the prognostic evaluation of patients with heart failure (HF) and identify those in whom the main cause of the reduced functional capacity is related to extracardiac factors.

BACKGROUND

Peak exercise oxygen consumption (VO₂) is one of the main prognostic variables in patients with HF, but it is influenced also by many extracardiac factors.

METHODS

Bicycle cardiopulmonary exercise testing with hemodynamic monitoring was performed, in addition to clinical evaluation and radionuclide ventriculography, in 219 consecutive patients with chronic HF (left ventricular ejection fraction, 22 ± 7%; peak VO₂, 14.2 ± 4.4 ml/kg/min).

RESULTS

During a follow-up of 19 ± 25 months, 32 patients died and 6 underwent urgent transplantation with a 71% cumulative major event-free 2-year survival. Peak exercise stroke work index (SWI) was the most powerful prognostic variable selected by Cox multivariate analysis, followed by serum sodium and left ventricular ejection fraction, for one-year survival, and peak VO₂ and serum sodium for two-year survival. Two-year survival was 54% in the patients with peak exercise SWI 30 g·m/m² versus 91% in those with a SWI >30 g·m/m² (p < 0.0001). A significant percentage of patients (41%) had a normal cardiac output response to exercise with an excellent two-year survival (87% vs. 58% in the others) despite a relatively low peak VO₂ (15.1 ± 4.7 ml/kg/min).

CONCLUSIONS

Direct assessment of exercise hemodynamics in patients with HF provides additive independent prognostic information, compared to traditional noninvasive data.

Abbreviations and Acronyms   ACE = angiotensin-converting enzyme   CO = cardiac output   HF = heart failure   LVEF = left ventricular ejection fraction   PWP = pulmonary wedge pressure   SWI = stroke work index   VO2 = oxygen consumption

This article has been cited by other articles:

				M. Metra, E. Eichhorn, W. T. Abraham, J. Linseman, M. Bohm, R. Corbalan, D. DeMets, T. De Marco, U. Elkayam, M. Gerber, et al. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials Eur. Heart J., August 22, 2009; (2009) ehp338v1. [Abstract] [Full Text] [PDF]

				A. Cohen-Solal, F. Beauvais, and L.-B. Tan Peak exercise responses in heart failure: back to basics Eur. Heart J., June 26, 2009; (2009) ehp176v1. [Full Text] [PDF]

				C. C. Lang, P. Karlin, J. Haythe, T. K. Lim, and D. M. Mancini Peak Cardiac Power Output, Measured Noninvasively, Is a Powerful Predictor of Outcome in Chronic Heart Failure Circ Heart Fail, January 1, 2009; 2(1): 33 - 38. [Abstract] [Full Text] [PDF]

				A. Cohen-Solal, F. Rouzet, A. Berdeaux, D. Le Guludec, E. Abergel, A. Syrota, and P. Merlet Effects of Carvedilol on Myocardial Sympathetic Innervation in Patients with Chronic Heart Failure J. Nucl. Med., November 1, 2005; 46(11): 1796 - 1803. [Abstract] [Full Text] [PDF]

				P. Agostoni, G. Cattadori, A. Apostolo, M. Contini, P. Palermo, G. Marenzi, and K. Wasserman Noninvasive Measurement of Cardiac Output During Exercise by Inert Gas Rebreathing Technique: A New Tool for Heart Failure Evaluation J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1779 - 1781. [Full Text] [PDF]

				U. Corra, A. Mezzani, E. Bosimini, and P. Giannuzzi Cardiopulmonary Exercise Testing and Prognosis in Chronic Heart Failure*: A Prognosticating Algorithm for the Individual Patient Chest, September 1, 2004; 126(3): 942 - 950. [Abstract] [Full Text] [PDF]

				F.X Kleber, P Waurick, and M Winterhalter CPET in heart failure Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D1 - D4. [Abstract] [Full Text] [PDF]

				S. Nodari, M. Metra, A. D. Cas, and L. D. Cas Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus Eur J Heart Fail, December 1, 2003; 5(6): 803 - 809. [Abstract] [Full Text] [PDF]

				S. Nodari, M. Metra, and L. D. Cas {beta}-Blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol Eur J Heart Fail, October 1, 2003; 5(5): 621 - 627. [Abstract] [Full Text] [PDF]

				L.B. Tan, S. G. Williams, and D.J. Wright Ventriculo-arterial function curves--a new dimension in characterising acute heart failure Eur J Heart Fail, August 1, 2003; 5(4): 407 - 410. [Full Text] [PDF]

				C. Scharf, T. Merz, W. Kiowski, E. Oechslin, C. Schalcher, and H. P. Brunner-La Rocca Noninvasive Assessment of Cardiac Pumping Capacity During Exercise Predicts Prognosis in Patients With Congestive Heart Failure Chest, October 1, 2002; 122(4): 1333 - 1339. [Abstract] [Full Text] [PDF]

				M Mejhert, E Linder-Klingsell, M Edner, T Kahan, and H Persson Ventilatory variables are strong prognostic markers in elderly patients with heart failure Heart, September 1, 2002; 88(3): 239 - 243. [Abstract] [Full Text] [PDF]

				D.P. Nicholls, C. O'Dochartaigh, and M.S. Riley Circulatory power--a new perspective on an old friend Eur. Heart J., August 2, 2002; 23(16): 1242 - 1245. [PDF]

				A. Cohen-Solal, J.Y. Tabet, D. Logeart, P. Bourgoin, M. Tokmakova, and M. Dahan A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure Eur. Heart J., May 2, 2002; 23(10): 806 - 814. [Abstract] [Full Text] [PDF]

				D.P. Nicholls and M.S. Riley Measuring cardiac power output--the acid test Eur. Heart J., August 2, 2001; 22(16): 1368 - 1370. [PDF]

				S.G Williams, G.A Cooke, D.J Wright, W.J Parsons, R.L Riley, P Marshall, and L-B Tan Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure Eur. Heart J., August 2, 2001; 22(16): 1496 - 1503. [Abstract] [PDF]

				Recommendations for exercise testing in chronic heart faliure patients Eur. Heart J., January 1, 2001; 22(1): 37 - 45. [PDF]

				M. Metra, R. Giubbini, S. Nodari, E. Boldi, M. G. Modena, and L. D. Cas Differential Effects of {beta}-Blockers in Patients With Heart Failure : A Prospective, Randomized, Double-Blind Comparison of the Long-Term Effects of Metoprolol Versus Carvedilol Circulation, August 1, 2000; 102(5): 546 - 551. [Abstract] [Full Text] [PDF]